Georgia State Menu
Georgia State Menu
  • Strategic Plan
  • Georgia State Menu
  • Georgia State Menu

Main navigation

Strategic Plan

Main navigation

pillar 1

pillar 1

2023-2033 Strategic Plan, News

Research Innovation and Scholarly Excellence (RISE) Challenge to Address Complex Societal Problems Through Interdisciplinary Collaboration

Research Innovation and Scholarly Excellence (RISE) Challenge to Address Complex Societal Problems Through Interdisciplinary Collaboration

Georgia State University will launch a new Research Innovation and Scholarly Excellence (RISE) challenge to address complex societal problems through interdisciplinary collaboration. The initiative aims to foster an innovative research ecosystem at the university and leverage the strengths of the Georgia State research community to address complex problems.

News

Research & Innovation: Center for Translational Antiviral Research Reports Novel Broad-Spectrum Antiviral Drug Class with Activity Against SARS-CoV-2

Research & Innovation: Center for Translational Antiviral Research Reports Novel Broad-Spectrum Antiviral Drug Class with Activity Against SARS-CoV-2

The COVID-19 pandemic and resurgence of infections by other respiratory RNA viruses such as respiratory syncytial virus (RSV) in children has caused an urgent need for the development of orally available broad-spectrum antiviral therapeutics.

In a study published online on Dec. 2 in Science, researchers in the Institute for Biomedical Sciences at Georgia State University report a new candidate ribonucleoside analog, 4’-fluorouridine (4’-FlU), that has potent antiviral activity against SARS-CoV-2, RSV and other respiratory RNA viruses in cell culture, human organoids and different animal models when administered orally once daily.